Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

2.8K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2020
Same author

Antibodies to vaccine antigens in pooled polyclonal human IgG products.

Transfusion·2018
Same author

IgPro20, the Polyneuropathy and Treatment with Hizentra<sup>®</sup> study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG.

Immunotherapy·2018
Same author

Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathies.

Journal of the peripheral nervous system : JPNS·2018
Same author

Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease.

Respiratory medicine·2017
Same author

Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation.

Blood reviews·2017

Related Experiment Video

Updated: May 4, 2026

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

11.0K

Subcutaneous IgG in neurologic diseases.

Melvin Berger1

  • 1Immunology Research & Development, CSL Behring, LLC, 1020 First Avenue, King of Prussia, PA 19406, USA and Pediatrics & Pathology, Case Western Reserve University, Cleveland, OH, USA. mel.berger@cslbehring.com.

Immunotherapy
|December 18, 2013
PubMed
Summary

Subcutaneous immunoglobulin (SCIG) therapy offers a safe and convenient alternative for autoimmune neuropathies. Patients prefer SCIG for its steady IgG levels and home administration over intravenous immunoglobulin.

More Related Videos

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
09:36

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis

Published on: June 23, 2022

3.5K
Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

483

Related Experiment Videos

Last Updated: May 4, 2026

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

11.0K
Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
09:36

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis

Published on: June 23, 2022

3.5K
Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

483

Area of Science:

  • Immunology
  • Neurology

Background:

  • Subcutaneous immunoglobulin (SCIG) is established for primary immune deficiencies.
  • Its use for autoimmune peripheral neuropathies (e.g., CIDP, MMN) is emerging.
  • Intravenous immunoglobulin (IVIg) has historically been the standard treatment.

Purpose of the Study:

  • To evaluate SCIG as a maintenance therapy for autoimmune peripheral neuropathies.
  • To compare SCIG's safety, tolerability, and patient preference against IVIg.
  • To assess the impact of SCIG's steady-state IgG levels on clinical stability.

Main Methods:

  • Weekly self-administration of SCIG.
  • Monitoring of serum IgG levels.
  • Assessment of safety, tolerability, and patient-reported outcomes.

Main Results:

  • Weekly SCIG is safe and well-tolerated in patients with autoimmune neuropathies.
  • SCIG achieves steady-state serum IgG levels, unlike IVIg's peaks and troughs.
  • Patients frequently prefer SCIG due to convenience, home administration, and flexibility.

Conclusions:

  • SCIG is a viable and preferred option for maintenance therapy in certain autoimmune neuropathies.
  • The steady IgG levels provided by SCIG may contribute to improved clinical stability.
  • Further long-term studies are necessary to confirm sustained clinical benefits and outcomes.